Returpen is the result of a collaboration across the healthcare ecosystem; Novo Nordisk (pharmaceutical company) teamed up with governmental bodies, healthcare providers, and diabetes and pharmaceutical associations to create positive impact on the environment.
The Returpen project is an example of an integrative partnership. Here, partners align their missions, strategies, values, and activities to achieve the priority goal of creating social impact.
In this collaboration, the partners have gone beyond sharing generic resources and developed a memorandum of understanding where they agree to join forces to enable the circularity of diabetes pens.
